165 related articles for article (PubMed ID: 30320906)
1. Synergistic antitumor activity of oridonin and valproic acid on HL-60 leukemia cells.
Li W; Ma L
J Cell Biochem; 2019 Apr; 120(4):5620-5627. PubMed ID: 30320906
[TBL] [Abstract][Full Text] [Related]
2. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.
Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G
Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928
[TBL] [Abstract][Full Text] [Related]
3. Oridonin induces apoptosis and cell cycle arrest of gallbladder cancer cells via the mitochondrial pathway.
Bao R; Shu Y; Wu X; Weng H; Ding Q; Cao Y; Li M; Mu J; Wu W; Ding Q; Tan Z; Liu T; Jiang L; Hu Y; Gu J; Liu Y
BMC Cancer; 2014 Mar; 14():217. PubMed ID: 24655726
[TBL] [Abstract][Full Text] [Related]
4. Oridonin exerts anticancer effect on osteosarcoma by activating PPAR-γ and inhibiting Nrf2 pathway.
Lu Y; Sun Y; Zhu J; Yu L; Jiang X; Zhang J; Dong X; Ma B; Zhang Q
Cell Death Dis; 2018 Jan; 9(1):15. PubMed ID: 29323103
[TBL] [Abstract][Full Text] [Related]
5. Oridonin induces apoptosis through the mitochondrial pathway in human gastric cancer SGC-7901 cells.
Gao S; Tan H; Zhu N; Gao H; Lv C; Gang J; Ji Y
Int J Oncol; 2016 Jun; 48(6):2453-60. PubMed ID: 27082253
[TBL] [Abstract][Full Text] [Related]
6. Oridonin effectively reverses the drug resistance of cisplatin involving induction of cell apoptosis and inhibition of MMP expression in human acute myeloid leukemia cells.
Zhang Y; Wang L; Zi Y; Zhang L; Guo Y; Huang Y
Saudi J Biol Sci; 2017 Mar; 24(3):678-686. PubMed ID: 28386196
[TBL] [Abstract][Full Text] [Related]
7. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.
Weng H; Huang H; Dong B; Zhao P; Zhou H; Qu L
Cancer Res; 2014 Aug; 74(16):4409-19. PubMed ID: 24872388
[TBL] [Abstract][Full Text] [Related]
9. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
10. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways.
Jiang JH; Pi J; Jin H; Cai JY
J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997
[TBL] [Abstract][Full Text] [Related]
11. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferation effects of oridonin on HPB-ALL cells and its mechanisms of action.
Liu JJ; Huang RW; Lin DJ; Wu XY; Peng J; Pan XL; Lin Q; Hou M; Zhang MH; Chen F
Am J Hematol; 2006 Feb; 81(2):86-94. PubMed ID: 16432862
[TBL] [Abstract][Full Text] [Related]
13. Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling.
Xia S; Zhang X; Li C; Guan H
Saudi Pharm J; 2017 May; 25(4):638-643. PubMed ID: 28579904
[TBL] [Abstract][Full Text] [Related]
14. Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.
Zhou GB; Kang H; Wang L; Gao L; Liu P; Xie J; Zhang FX; Weng XQ; Shen ZX; Chen J; Gu LJ; Yan M; Zhang DE; Chen SJ; Wang ZY; Chen Z
Blood; 2007 Apr; 109(8):3441-50. PubMed ID: 17197433
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
Kang N; Zhang JH; Qiu F; Tashiro S; Onodera S; Ikejima T
Cancer Lett; 2010 Aug; 294(2):147-58. PubMed ID: 20202741
[TBL] [Abstract][Full Text] [Related]
16. Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
Wang H; Zhu L; Feng X; Zhang H; Luo Q; Chen F
Eur J Pharmacol; 2017 Nov; 815():282-289. PubMed ID: 28935563
[TBL] [Abstract][Full Text] [Related]
17. Oridonin inhibits oral cancer growth and PI3K/Akt signaling pathway.
Yang J; Ren X; Zhang L; Li Y; Cheng B; Xia J
Biomed Pharmacother; 2018 Apr; 100():226-232. PubMed ID: 29432993
[TBL] [Abstract][Full Text] [Related]
18. Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-kappa B signal pathways.
Ikezoe T; Yang Y; Bandobashi K; Saito T; Takemoto S; Machida H; Togitani K; Koeffler HP; Taguchi H
Mol Cancer Ther; 2005 Apr; 4(4):578-86. PubMed ID: 15827331
[TBL] [Abstract][Full Text] [Related]
19. Oridonin inhibits hypoxia-induced epithelial-mesenchymal transition and cell migration by the hypoxia-inducible factor-1α/matrix metallopeptidase-9 signal pathway in gallbladder cancer.
Chen K; Ye J; Qi L; Liao Y; Li R; Song S; Zhou C; Feng R; Zhai W
Anticancer Drugs; 2019 Oct; 30(9):925-932. PubMed ID: 31517732
[TBL] [Abstract][Full Text] [Related]
20. [Anti-leukemia effect of oridonin on T-cell acute lymphoblastic leukemia].
Guo Y; Shan QQ; Gong YP; Lin J; Yang X
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):903-7. PubMed ID: 25571712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
